We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Dermata Therapeutics Inc | NASDAQ:DRMA | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-0.11 | -3.25% | 3.27 | 3.26 | 3.69 | 3.54 | 3.27 | 3.40 | 13,628 | 21:34:23 |
| THE PURPOSES OF THIS MEETING ARE AS FOLLOWS: | |
|
| |
| 1. | TO ELECT THREE DIRECTOR NOMINEES TO SERVE AS DIRECTORS UNTIL THE 2026 ANNUAL MEETING OF STOCKHOLDERS; |
|
|
|
| 2. | TO RATIFY THE APPOINTMENT OF MAYER HOFFMAN MCCANN P.C. AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE YEAR ENDING DECEMBER 31, 2023; |
|
|
|
| 3. | TO APPROVE AN AMENDMENT TO THE DERMATA THERAPEUTICS, INC. 2021 OMNIBUS EQUITY INCENTIVE PLAN (THE “2021 PLAN”) TO INCREASE THE NUMBER OF THE SHARES OF COMMON STOCK AUTHORIZED FOR ISSUANCE THEREUNDER BY 513,150 SHARES TO 629,069 SHARES; AND |
|
|
|
| 4. | TO CONSIDER ANY OTHER MATTERS THAT MAY PROPERLY COME BEFORE THE ANNUAL MEETING. |
|
|
|
PURSUANT TO SECURITIES AND EXCHANGE COMMISSION RULES, YOU ARE RECEIVING THIS NOTICE THAT THE PROXY MATERIALS FOR THE ANNUAL MEETING
ARE AVAILABLE ON THE INTERNET. FOLLOW THE INSTRUCTIONS ABOVE TO VIEW THE MATERIALS AND VOTE OR REQUEST PRINTED COPIES.
THE BOARD OF DIRECTORS HAS FIXED THE CLOSE OF BUSINESS ON JUNE 5, 2023 AS THE RECORD DATE FOR THE DETERMINATION OF STOCKHOLDERS ENTITLED
TO RECEIVE NOTICE OF THE ANNUAL MEETING AND TO VOTE THE SHARES OF THE COMPANY’S COMMON STOCK, THEY HELD ON THAT DATE AT THE MEETING OR
ANY POSTPONEMENT OR ADJOURNMENT OF THE MEETING.
THE BOARD OF DIRECTORS RECOMMENDS THAT YOU VOTE ‘FOR’ ALL PROPOSALS ABOVE.
PLEASE NOTE - THIS IS NOT A PROXY CARD - YOU CANNOT VOTE BY RETURNING THIS CARD
Dermata Therapeutics, Inc. SHAREHOLDER SERVICES 1 Glenwood Avenue Suite 1001 Raleigh NC 27603 |
| FIRST-CLASS MAIL US POSTAGE PAID RALEIGH NC PERMIT # 870 |
TIME SENSITIVE SHAREHOLDER INFORMATION ENCLOSED
IMPORTANT SHAREHOLDER INFORMATION
YOUR VOTE IS IMPORTANT
2 |
1 Year Dermata Therapeutics Chart |
1 Month Dermata Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions